ClinicalTrials.gg
RecruitingNCT07712432INDOLCUpdated Sep 3, 2026

Insomnia and Post-Dental Surgery Pain: A Prospective Study

An observational study in Dental, Dental Extraction and Insomnia, sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS. Recruiting at 1 site in Italy. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-03.

Sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Observational

From the registry’s dates

  • Started Sep 2026; still recruiting 2 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
90
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this prospective observational study is to evaluate the relationship between preoperative sleep disturbances-specifically insomnia-and postoperative pain intensity following oral surgical procedures. Recent scientific literature highlights a bidirectional relationship between sleep disorders and pain in dentistry, suggesting that disturbed sleep may actively exacerbate subsequent pain perception. Although postoperative pain, swelling, and masticatory difficulties are common after dental extractions, clinical data investigating the direct impact of preoperative sleep quality on these surgical outcomes remain scarce. This study will enroll adult patients undergoing routine dental extractions and allocate them into two cohorts based on their baseline sleep quality: patients without preoperative sleep disturbances and patients with preoperative sleep disturbances. Pain levels and sleep parameters will be assessed using validated questionnaires before the surgery and at a 7-day follow-up. The primary objective is to determine whether the presence of preoperative insomnia leads to a significant increase in perceived postoperative surgical pain.

Read the detailed description

Study Design and Setting This is a single-center, prospective, non-profit observational cohort study conducted at the Fondazione Policlinico Universitario A. Gemelli IRCCS. The study will span a total duration of 24 months: 18 months dedicated to patient recruitment and data collection, followed by 6 months dedicated to data processing and statistical analysis.

Patient data collection will begin only after obtaining explicit written informed consent and formal protocol approval from the Institutional Ethics Committee. Participant Recruitment and Timeline

Adult patients scheduled for dental extractions who meet the inclusion criteria will be invited to participate. Eligible individuals will be excluded if they are pregnant, present relevant comorbidities, experience acute pain/infections at recruitment, or take medications that interfere with sleep or pain management. The clinical workflow consists of the following phases:

  1. Baseline (Pre-surgery):

    Prior to the extraction procedure, participants will complete a comprehensive set of validated psychometric and sleep questionnaires. Based on these initial assessments, patients will be classified into two parallel cohorts:

    • Group 1 (patients without preoperative sleep disturbances) and
    • Group 2 (patients with preoperative sleep disturbances).
  2. Intraoperative Assessment: Immediately following the dental extraction, patients will record the level of pain perceived during the surgical procedure. 3. Postoperative Follow-up (Days 1-7): Over the subsequent 7 days, participants will maintain a standardized daily paper diary to monitor daily pain intensity and log the frequency and type of any analgesic medications consumed.
  3. 7-Day Follow-up Visit: At the scheduled 7-day postoperative clinical control visit, patients will return their completed paper diaries and re-submit the same set of baseline questionnaires to track changes in sleep and psychological parameters.

Evaluated Instruments and Questionnaires

To thoroughly investigate the primary and secondary endpoints, the study utilizes the following validated instruments:

  • Visual Analog Scale (VAS 0-100): Used to measure changes in perceived pain intensity from baseline to day 7.
  • Insomnia Severity Index (ISI): A 7-item questionnaire (score range 0-28) evaluating insomnia severity over the past two weeks.
  • Pittsburgh Sleep Quality Index (PSQI): A 19-item instrument (global score range 0-21) measuring overall sleep quality over the past 4 weeks.
  • Berlin Questionnaire: A specialized screening tool to identify patients at low or high risk for Obstructive Sleep Apnea Syndrome (OSAS).
  • Patient Health Questionnaire-4 (PHQ-4): An ultra-brief 4-item screening scale used to assess psychological distress, split into anxiety and depressive symptoms.

Statistical Analysis Overview Sample size calculations, conservatively adjusted based on relevant literature, dictate a minimum enrollment of 90 subjects (45 per group) to achieve 80% statistical power. Continuous variables will be evaluated for normality via the Shapiro-Wilk test. Differences in pre- versus post-operative quantitative metrics will be evaluated using paired t-tests or Wilcoxon signed-rank tests, while categorical variables will be assessed via Chi-squared or Fisher's exact tests. Multivariate linear regression models, repeated measures ANOVA, and mixed-effects models for longitudinal data will be implemented to isolate independent predictors of pain variation and identify distinct trajectories across the cohorts, adjusting for confounding factors such as age, sex, and extraction type (simple vs. surgical). Analysis will be performed using SPSS software.

02

Conditions studied

  • Dental
  • Dental Extraction
  • Insomnia

Keywords

  • Insomnia
  • Oral disease
03

In context

Sleep Initiation and Maintenance Disorders

2,722 studies on the registry are indexed under Sleep Initiation and Maintenance Disorders; 726 are open to participants now.

This study's planned enrollment of 90 is below the median of 138 across 318 observational studies indexed under Sleep Initiation and Maintenance Disorders.

Browse Sleep Initiation and Maintenance Disorders studies →

Lead sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS is the lead sponsor of 952 studies on the registry; 541 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population consists of an adult population of both sexes, aged 18 years or older, who are scheduled to undergo an odontoiatric surgical intervention, specifically dental extractions, at the Fondazione Policlinico Universitario A. Gemelli IRCCS.

This population will be selected based on specific eligibility criteria and will be divided into two distinct cohorts at baseline to evaluate the impact of sleep health on surgical outcomes:

Group 1 (Control Cohort): Adult patients undergoing dental extractions who do not exhibit preoperative sleep disturbances.

Group 2 (Exposed Cohort): Adult patients undergoing dental extractions who present with pre-existing preoperative sleep disturbances.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age over or egual 18 years.
  • Need for odontoiatric surgical intervention (dental extractions).
  • Willingness to participate in the study by completing the proposed questionnaires.
  • Good understanding of the Italian language.
  • Ability to understand and sign the form.

Exclusion criteria

Exclusion Criteria:

  • Pharmacological therapy interfering with sleep or pain at the time of recruitment.
  • Acute pain or ongoing infections at the time of recruitment.
  • Relevant comorbidities.
  • Pregnancy.
  • Impossibility to complete the follow-up.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
90 participants (estimated)
Patient registry
No

Groups and cohorts

  • Patients without preoperative sleep disturbance

    Adult patients undergoing dental extractions who do not exhibit preoperative sleep disturbances. Target Number: 45 participants.

  • Patients with preoperative sleep disturbance

    Adult patients undergoing dental extractions who exhibit preoperative sleep disturbances. Target number: 45 participants.

06

What researchers measure

Primary outcomes

  1. Change in Perceived Pain Intensity (VAS)

    Perceived pain evaluated using the Visual Analog Scale (VAS 0-100), where higher scores indicate greater pain intensity. The outcome is measured as the change in pain score from baseline to 7 days post-extraction.

    Time frame: Baseline (pre-surgery) and 7 days post-dental extraction.

Secondary outcomes

  1. Analgesic Medication Use

    Monitoring the daily frequency of intake and the specific type of analgesic medication used, recorded through a daily paper diary.

    Time frame: Daily, for 7 days following the surgical procedure.

  2. Insomnia Severity Index (ISI) Score

    Assessment of insomnia severity using the validated 7-item ISI questionnaire (total score ranges from 0 to 28; scores $\\ge 15$ indicate clinically significant insomnia).

    Time frame: Baseline (pre-surgery) and 7 days post-surgery.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — Data will be processed in an anonymous form, linked to an identification code, and kept as a confidential document accessible only to the Principal Investigator and collaborators at the trial site.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2026 (actual). Primary completion is estimated for Nov 2026, 2 months after the start.

Of 127 non-industry observational studies under Sleep Initiation and Maintenance Disorders, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 42. This study's planned 2 months is below that.

Counting every sponsor, half of 137 studies reached it within 18 months; a quarter within 4 and three quarters within 40.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 14, 2026
First posted
Jul 17, 2026
StartActual
Sep 1, 2026
Primary completionEst.
Nov 2026
CompletionEst.
Jun 2027
Last update
Sep 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07712432
Responsible party
Sponsor
First posted
Jul 17, 2026
Start date
Sep 1, 2026
Primary completion
Nov 2026 (estimated)
Completion
Jun 2027 (estimated)
Last update
Sep 3, 2026

Study contacts

Prof. Patrizia Gallenzi
Contact
patrizia.gallenzi@unicatt.it
+39 063015 5413
Patrizia Gallenzi
principal investigator · Fondazione Policlinico A. Gemelli IRCCS

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion